Wanjun Ren1, Huili Jiang1, Yuejuan Du1, Fang Liu1, Xiaoping Wang1, Dongmei Xu2. 1. Department of Nephrology and Blood Purification Center, Jinan City Central Hospital, Shandong University, No. 105. Jiefang Road, Jinan, 250012, China. 2. Department of Nephrology, Qianfoshan Hospital, Shandong University, No. 16766. Jingshi Road, Jinan, 250011, Shandong, China. dongmeixk@tom.com.
Abstract
PURPOSE: This study was designed to evaluate the long-term patency rate and complications associated with early use of the autogenous forearm arteriovenous fistula (AFAVF) in patients needing urgent hemodialysis. METHODS: The clinical data of all patients undergoing AFAVFs for hemodialysis access between June 1996 and June 2016 were retrospectively evaluated. The primary and secondary patencies were estimated using the life table method. RESULTS: A total of 104 AFAVFs were created for 102 patients. All patients had entered hemodialysis when fistulas were constructed. The mean time to the first cannulation of the AFAVF was 17.33 ± 4.60 (5-27 days). Four AFAVFs (3.8%) became occluded within 30 days of creation of the access, and five AFAVFs (4.8%) had hematomas after cannulation. There were no cases of infection of the wound or steal syndrome or prolonged arm edema. The primary patency rate was 77.81% at 1 year, 73.05% at 2 years, 64.64% at 3 years, 60.75% at 5 years and 47.48% at 10 years. The secondary patency rate was 96.78% at 1 year, 95.18% at 5 years and 85.81% at 10 years. CONCLUSIONS: In this study, the patency rates following the early use of the AFAVFs were not inferior to the previously reported patency rates in the literature. For patients entering hemodialysis with an inserted central catheter, the early use of the AFAVFs decreases the complications associated with catheters.
PURPOSE: This study was designed to evaluate the long-term patency rate and complications associated with early use of the autogenous forearm arteriovenous fistula (AFAVF) in patients needing urgent hemodialysis. METHODS: The clinical data of all patients undergoing AFAVFs for hemodialysis access between June 1996 and June 2016 were retrospectively evaluated. The primary and secondary patencies were estimated using the life table method. RESULTS: A total of 104 AFAVFs were created for 102 patients. All patients had entered hemodialysis when fistulas were constructed. The mean time to the first cannulation of the AFAVF was 17.33 ± 4.60 (5-27 days). Four AFAVFs (3.8%) became occluded within 30 days of creation of the access, and five AFAVFs (4.8%) had hematomas after cannulation. There were no cases of infection of the wound or steal syndrome or prolonged arm edema. The primary patency rate was 77.81% at 1 year, 73.05% at 2 years, 64.64% at 3 years, 60.75% at 5 years and 47.48% at 10 years. The secondary patency rate was 96.78% at 1 year, 95.18% at 5 years and 85.81% at 10 years. CONCLUSIONS: In this study, the patency rates following the early use of the AFAVFs were not inferior to the previously reported patency rates in the literature. For patients entering hemodialysis with an inserted central catheter, the early use of the AFAVFs decreases the complications associated with catheters.
Authors: M B Silva; R W Hobson; P J Pappas; Z Jamil; C T Araki; M C Goldberg; G Gwertzman; F T Padberg Journal: J Vasc Surg Date: 1998-02 Impact factor: 4.268
Authors: Rajiv Saran; Dawn M Dykstra; Ronald L Pisoni; Takashi Akiba; Tadao Akizawa; Bernard Canaud; Kenneth Chen; Luis Piera; Akira Saito; Eric W Young Journal: Nephrol Dial Transplant Date: 2004-07-13 Impact factor: 5.992
Authors: Nicholas Fassiadis; Mohamed Morsy; Mayooran Siva; James E Marsh; A David Makanjuola; Eric S Chemla Journal: Semin Dial Date: 2007 Sep-Oct Impact factor: 3.455
Authors: Michelle L Robbin; Nathan E Chamberlain; Mark E Lockhart; Michael H Gallichio; Carlton J Young; Mark H Deierhoi; Michael Allon Journal: Radiology Date: 2002-10 Impact factor: 11.105